Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John-Michael Gamble

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of General Internal Medicine|June 8, 2011
Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysisScot H Simpson, John-Michael Gamble, Laurie Mereu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 1, 2022
Association between Inhaled β<sub>2</sub>-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control StudyJoseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell, et al.
Respiratory Research|December 20, 2022
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlapJoseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 16, 2020
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based StudyJoseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2026
Hospitalization for Malignant Arrhythmias Following Initiation of Donepezil: A Retrospective Cohort StudyYichang Huang, John-Michael Gamble, David N Juurlink, et al.
Drugs - Real World Outcomes|September 29, 2017
The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose SimvastatinKanika Anand, Ingrid Sketris, Ying Zhang, et al.
Clinical Therapeutics|May 5, 2012
Restrictive drug coverage policies can induce substantial drug exposure misclassification in pharmacoepidemiologic studiesJohn-Michael Gamble, Finlay A McAlister, Jeffrey A Johnson, et al.
PLOS Mental Health|March 25, 2026
Reinitiation of antidepressant pharmacotherapy among patients discharged from the hospital: A population-based cohort studyWaseem Abu-Ashour, John-Michael Gamble, John Hawboldt, et al.
Canadian Journal of Diabetes|December 11, 2013
Use patterns of antidiabetic regimens by patients with type 2 diabetesAhmed S Abdelmoneim, Dean T Eurich, John-Michael Gamble, et al.
Canadian Journal of Diabetes|April 30, 2022
Trends and Determinants of Self-reported Aspirin Use Among Patients With Diabetes Stratified by Presence and Risk of Cardiovascular Diseases: A Repeated Pan-Canadian Cross-sectional StudyNathan Seng Bong Ing, Razan Amoud, John-Michael Gamble, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of General Internal Medicine|June 8, 2011
Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysisScot H Simpson, John-Michael Gamble, Laurie Mereu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 1, 2022
Association between Inhaled β<sub>2</sub>-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control StudyJoseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell, et al.
Respiratory Research|December 20, 2022
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlapJoseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 16, 2020
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based StudyJoseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2026
Hospitalization for Malignant Arrhythmias Following Initiation of Donepezil: A Retrospective Cohort StudyYichang Huang, John-Michael Gamble, David N Juurlink, et al.
Drugs - Real World Outcomes|September 29, 2017
The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose SimvastatinKanika Anand, Ingrid Sketris, Ying Zhang, et al.
Clinical Therapeutics|May 5, 2012
Restrictive drug coverage policies can induce substantial drug exposure misclassification in pharmacoepidemiologic studiesJohn-Michael Gamble, Finlay A McAlister, Jeffrey A Johnson, et al.
PLOS Mental Health|March 25, 2026
Reinitiation of antidepressant pharmacotherapy among patients discharged from the hospital: A population-based cohort studyWaseem Abu-Ashour, John-Michael Gamble, John Hawboldt, et al.
Canadian Journal of Diabetes|December 11, 2013
Use patterns of antidiabetic regimens by patients with type 2 diabetesAhmed S Abdelmoneim, Dean T Eurich, John-Michael Gamble, et al.
Canadian Journal of Diabetes|April 30, 2022
Trends and Determinants of Self-reported Aspirin Use Among Patients With Diabetes Stratified by Presence and Risk of Cardiovascular Diseases: A Repeated Pan-Canadian Cross-sectional StudyNathan Seng Bong Ing, Razan Amoud, John-Michael Gamble, et al.
Pageof 8